InsiderTrades

Form 4 for ALKS Alkermes plc.

Accepted 2025-12-05 00:00:00 ET · period of report 2025-12-03 · accession 0001520262-25-000014 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-12-05 2025-12-03 ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off M - OptEx $19.34 +3,748 69.5K +6% +$72.5K
D 2025-12-05 2025-12-03 ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off S - Sale+OE $30.00 -3,748 65.7K -5% -$112.4K
D 2025-12-05 2025-12-03 ALKS Hopkinson Craig C. EVP R, D, Chief Medical Off M - OptEx $0.00 -3,748 36.4K -9% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2025-12-03 M A 3,748 $19.34 69,488 D — —
2 Common Ordinary Shares 2025-12-03 S D 3,748 $30.00 65,740 D — — (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.03. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request.
3 Derivative Employee Stock Option (Right to Buy) 2025-12-03 M D 3,748 $0.00 36,356 D $19.34 · — to 2031-02-22 3,748 Ordinary Shares (F4) These options are fully vested in accordance with their terms.